{
    "organizations": [],
    "uuid": "3709b3668a0d851cef5810ff99a5ae89f5aaf84d",
    "author": "",
    "url": "https://www.reuters.com/article/brief-immunoprecise-to-invest-in-single/brief-immunoprecise-to-invest-in-single-cells-foundational-technology-idUSFWN1PH0OB",
    "ord_in_thread": 0,
    "title": "BRIEF-ImmunoPrecise To Invest In Single Cell's Foundational Technology",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "January 22, 2018 / 1:57 PM / in 20 minutes BRIEF-ImmunoPrecise To Invest In Single Cell's Foundational Technology Reuters Staff \nJan 22 (Reuters) - Immunoprecise Antibodies Ltd: \n* IMMUNOPRECISE TO STRATEGICALLY INVEST IN FOUNDATIONAL NEXT GENERATION ANTIBODY DISCOVERY TECHNOLOGY \n* IMMUNOPRECISE ANTIBODIES - ‍AGREED TO INVEST $5 MILLION IN EXPANSION & DEVELOPMENT OF PRODUCTION CAPABILITY FOR SINGLE CELL‘S FOUNDATIONAL TECHNOLOGY​ \n* IMMUNOPRECISE ANTIBODIES - INVESTMENT WILL RESULT IN CO OWNING ABOUT 10% OF ISSUED AND OUTSTANDING SHARES OF SINGLE CELL Source text for Eikon: Further company coverage:",
    "published": "2018-01-22T15:56:00.000+02:00",
    "crawled": "2018-01-22T16:02:56.006+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "husky", 
        "beanpot",
        "northeastern",
        "january",
        "pm",
        "minute",
        "invest",
        "single",
        "cell",
        "foundational",
        "technology",
        "reuters",
        "staff",
        "jan",
        "reuters",
        "immunoprecise",
        "antibody",
        "ltd",
        "immunoprecise",
        "strategically",
        "invest",
        "foundational",
        "next",
        "generation",
        "antibody",
        "discovery",
        "technology",
        "immunoprecise",
        "antibody",
        "invest",
        "million",
        "expansion",
        "development",
        "production",
        "capability",
        "single",
        "cell",
        "foundational",
        "immunoprecise",
        "antibody",
        "investment",
        "result",
        "co",
        "owning",
        "issued",
        "outstanding",
        "share",
        "single",
        "cell",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}
